Sign in
4

Changes in Ownership

Janux Therapeutics, Inc. Filed Acc 0001415889-24-028203

President and CEO sold 15,000 shares at $67.00 ($1,005,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Campbell David Alan · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-03 Sale : show line 1 in the form 10b5-1 −15,000 $67.00 $1,005,000 242,054 D
Open-market sales · 15,000 sh · avg $67.00 · $1,005,000
Loading xslF345X05/form4-12032024_081201.xml…